• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过蛋白质组学和靶向代谢物分析揭示了尿中氯胺酮和 APOA1 水平与氯胺酮滥用者膀胱功能障碍的关联。

Association of urinary ketamine and APOA1 levels with bladder dysfunction in ketamine abusers revealed via proteomics and targeted metabolite analyses.

机构信息

Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.

Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.

出版信息

Sci Rep. 2021 May 5;11(1):9583. doi: 10.1038/s41598-021-89089-4.

DOI:10.1038/s41598-021-89089-4
PMID:33953300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8099891/
Abstract

Chronic ketamine abuse is associated with bladder dysfunction and cystitis. However, the effects of ketamine abuse on the urinary proteome profile and the correlations among urinary proteins, urinary ketamine (and metabolites) and clinicopathological features of ketamine-induced bladder dysfunction remain to be established. Here, we recruited 56 ketamine abusers (KA) and 40 age-matched healthy controls (HC) and applied the iTRAQ-based proteomics approach to unravel quantitative changes in the urine proteome profile between the two groups. Many of the differentially regulated proteins are involved in the complement and coagulation cascades and/or fibrotic disease. Among them, a significant increase in APOA1 levels in KA relative to control samples (392.1 ± 59.9 ng/ml vs. 13.7 ± 32.6 ng/ml, p < 0.0001) was detected via ELISA. Moreover, urinary ketamine, norketamine and dehydronorketamine contents (measured via LC-SRM-MS) were found to be positively correlated with overactive bladder syndrome score (OABSS) and APOA1 levels with urinary RBC, WBC, OABSS and numeric pain rating scale in KA. Collectively, our results may aid in developing new molecular tool(s) for management of ketamine-induced bladder dysfunction. Moreover, information regarding the differentially regulated proteins in urine of KA provides valuable clues to establish the molecular mechanisms underlying ketamine-induced cystitis.

摘要

慢性氯胺酮滥用与膀胱功能障碍和膀胱炎有关。然而,氯胺酮滥用对尿蛋白质组谱的影响,以及尿中氯胺酮(及其代谢物)与氯胺酮诱导的膀胱功能障碍的临床病理特征之间的相关性,仍有待确定。在这里,我们招募了 56 名氯胺酮滥用者(KA)和 40 名年龄匹配的健康对照者(HC),并应用 iTRAQ 基于蛋白质组学方法来揭示两组之间尿液蛋白质组谱的定量变化。许多差异调节的蛋白质参与补体和凝血级联反应和/或纤维化疾病。其中,通过 ELISA 检测到 KA 中 APOA1 水平相对于对照样本显著增加(392.1 ± 59.9 ng/ml 比 13.7 ± 32.6 ng/ml,p < 0.0001)。此外,通过 LC-SRM-MS 测量的尿中氯胺酮、去甲氯胺酮和脱水去甲氯胺酮含量与膀胱过度活动症评分(OABSS)呈正相关,而 APOA1 水平与 KA 中的尿 RBC、WBC、OABSS 和数字疼痛评分呈正相关。总之,我们的研究结果可能有助于开发管理氯胺酮诱导的膀胱功能障碍的新分子工具。此外,KA 尿液中差异调节蛋白质的信息为建立氯胺酮诱导的膀胱炎的分子机制提供了有价值的线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1abd/8099891/c64b343a4816/41598_2021_89089_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1abd/8099891/2d2a081bca9c/41598_2021_89089_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1abd/8099891/4826e0f280fc/41598_2021_89089_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1abd/8099891/2bbcd3488381/41598_2021_89089_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1abd/8099891/c64b343a4816/41598_2021_89089_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1abd/8099891/2d2a081bca9c/41598_2021_89089_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1abd/8099891/4826e0f280fc/41598_2021_89089_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1abd/8099891/2bbcd3488381/41598_2021_89089_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1abd/8099891/c64b343a4816/41598_2021_89089_Fig4_HTML.jpg

相似文献

1
Association of urinary ketamine and APOA1 levels with bladder dysfunction in ketamine abusers revealed via proteomics and targeted metabolite analyses.通过蛋白质组学和靶向代谢物分析揭示了尿中氯胺酮和 APOA1 水平与氯胺酮滥用者膀胱功能障碍的关联。
Sci Rep. 2021 May 5;11(1):9583. doi: 10.1038/s41598-021-89089-4.
2
Long-term ketamine abuse induces cystitis in rats by impairing the bladder epithelial barrier.长期滥用氯胺酮通过损害膀胱上皮屏障诱导大鼠膀胱炎。
Mol Biol Rep. 2014 Nov;41(11):7313-22. doi: 10.1007/s11033-014-3616-5. Epub 2014 Aug 5.
3
Clinical Outcome of Augmentation Enterocystoplasty for Patients with Ketamine-induced Cystitis.氯胺酮诱导的膀胱炎患者行扩大肠膀胱成形术的临床结局
Pain Physician. 2017 Mar;20(3):E431-E436.
4
Validation of an enzyme-linked immunosorbent assay screening method and a liquid chromatography-tandem mass spectrometry confirmation method for the identification and quantification of ketamine and norketamine in urine samples from Malaysia.用于鉴定和定量马来西亚尿液样本中氯胺酮和去甲氯胺酮的酶联免疫吸附测定筛选方法及液相色谱-串联质谱确证方法的验证
J Anal Toxicol. 2009 Jul-Aug;33(6):310-21. doi: 10.1093/jat/33.6.310.
5
A fast screening procedure for ketamine and metabolites in urine samples with tandem mass spectrometry.串联质谱法快速筛选尿液样本中的氯胺酮及其代谢物。
J Anal Toxicol. 2010 Apr;34(3):149-54. doi: 10.1093/jat/34.3.149.
6
Enantioselective analysis of ketamine and its metabolites in equine plasma and urine by CE with multiple isomer sulfated beta-CD.采用带有多种异构体硫酸化β-环糊精的毛细管电泳法对马血浆和尿液中的氯胺酮及其代谢物进行对映体选择性分析。
Electrophoresis. 2007 Aug;28(15):2748-57. doi: 10.1002/elps.200600820.
7
Prolonged Ketamine and Norketamine Excretion Profiles in Urine After Chronic Use: A Case Series.慢性使用后尿液中氯胺酮和去甲氯胺酮的延长排泄谱:病例系列。
J Clin Psychopharmacol. 2020 May/Jun;40(3):300-304. doi: 10.1097/JCP.0000000000001191.
8
Urine concentrations of ketamine and norketamine following illegal consumption.非法服用后尿液中氯胺酮和去甲氯胺酮的浓度。
J Anal Toxicol. 2001 Oct;25(7):583-8. doi: 10.1093/jat/25.7.583.
9
Increased Nectin-4 levels in chronic ketamine abusers and the relationship with lower urinary tract symptoms.慢性氯胺酮滥用者中 Nectin-4 水平升高及其与下尿路症状的关系。
Environ Toxicol Pharmacol. 2021 Oct;87:103714. doi: 10.1016/j.etap.2021.103714. Epub 2021 Jul 22.
10
Evaluation of urinary bladder fibrogenesis in a mouse model of long-term ketamine injection.长期注射氯胺酮小鼠模型中膀胱纤维化形成的评估。
Mol Med Rep. 2016 Sep;14(3):1880-90. doi: 10.3892/mmr.2016.5482. Epub 2016 Jul 7.

引用本文的文献

1
Ketamine Inhalation Alters Behavior and Lower Urinary Tract Function in Mice.氯胺酮吸入改变小鼠行为和下尿路功能。
Biomedicines. 2022 Dec 28;11(1):75. doi: 10.3390/biomedicines11010075.
2
Identification of Fucosylated SERPINA1 as a Novel Plasma Marker for Pancreatic Cancer Using Lectin Affinity Capture Coupled with iTRAQ-Based Quantitative Glycoproteomics.采用凝集素亲和捕获联合 iTRAQ 基于定量糖蛋白质组学技术鉴定唾液酸化丝氨酸蛋白酶抑制剂 A1 作为胰腺癌的新型血浆标志物。
Int J Mol Sci. 2021 Jun 4;22(11):6079. doi: 10.3390/ijms22116079.

本文引用的文献

1
TMT-labelled quantitative proteomic analysis to identify the proteins underlying radiation-induced colorectal fibrosis in rats.TMT 标记定量蛋白质组学分析鉴定大鼠放射性结直肠纤维化相关蛋白。
J Proteomics. 2020 Jul 15;223:103801. doi: 10.1016/j.jprot.2020.103801. Epub 2020 May 5.
2
FibroAtlas: A Database for the Exploration of Fibrotic Diseases and Their Genes.纤维图谱:一个用于探索纤维化疾病及其基因的数据库。
Cardiol Res Pract. 2019 Dec 30;2019:4237285. doi: 10.1155/2019/4237285. eCollection 2019.
3
Ketamine induces endoplasmic reticulum stress in rats and SV-HUC-1 human uroepithelial cells by activating NLRP3/TXNIP aix.
氯胺酮通过激活 NLRP3/TXNIP 轴诱导大鼠和 SV-HUC-1 人尿路上皮细胞内质网应激。
Biosci Rep. 2019 Oct 30;39(10). doi: 10.1042/BSR20190595.
4
A survey for ketamine abuse and its relation to the lower urinary tract symptoms in Taiwan.台湾氯胺酮滥用及其与下尿路症状的关系调查。
Sci Rep. 2019 May 10;9(1):7240. doi: 10.1038/s41598-019-43746-x.
5
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.STRING v11:具有增强覆盖范围的蛋白质-蛋白质相互作用网络,支持在全基因组实验数据集的功能发现。
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613. doi: 10.1093/nar/gky1131.
6
Changes to the bladder epithelial barrier are associated with ketamine-induced cystitis.膀胱上皮屏障的改变与氯胺酮诱导的膀胱炎有关。
Exp Ther Med. 2017 Oct;14(4):2757-2762. doi: 10.3892/etm.2017.4913. Epub 2017 Aug 9.
7
The putative involvement of actin-binding proteins and cytoskeleton proteins in pathological mechanisms of ketamine cystitis-Revealed by a prospective pilot study using proteomic approaches.肌动蛋白结合蛋白和细胞骨架蛋白在氯胺酮膀胱炎病理机制中的假定作用——一项使用蛋白质组学方法的前瞻性初步研究揭示
Proteomics Clin Appl. 2017 Mar;11(3-4). doi: 10.1002/prca.201600085. Epub 2016 Dec 21.
8
Microvascular Injury in Ketamine-Induced Bladder Dysfunction.氯胺酮诱导的膀胱功能障碍中的微血管损伤
PLoS One. 2016 Aug 16;11(8):e0160578. doi: 10.1371/journal.pone.0160578. eCollection 2016.
9
Evaluation of urinary bladder fibrogenesis in a mouse model of long-term ketamine injection.长期注射氯胺酮小鼠模型中膀胱纤维化形成的评估。
Mol Med Rep. 2016 Sep;14(3):1880-90. doi: 10.3892/mmr.2016.5482. Epub 2016 Jul 7.
10
Apolipoprotein A-I: A Molecule of Diverse Function.载脂蛋白A-I:一种具有多种功能的分子。
Indian J Clin Biochem. 2016 Jul;31(3):253-9. doi: 10.1007/s12291-015-0513-1. Epub 2015 Jul 16.